Korsana Biosciences KRSA
NASDAQ KRSA
$30.25 -3.75 (-11.03%)
As of: Sep 30, 2026 · 10:23 AM EDT

Korsana Biosciences (KRSA) Receivables - Other (2019 - 2020)

Updated

Korsana Biosciences' Receivables - Other came in at $127,000 for Q4 2020, down 91.4% from $1.47 million a year earlier and down 68.3% from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Receivables - Other (2019 - 2020) Analysis & Trends

Going back to Q2 2019, Korsana Biosciences' Receivables - Other data covers 7 quarters.

  • Going back by year, Receivables - Other was $1.5 million in FY2019.
  • Year-over-year, Receivables - Other has declined for three consecutive quarters.
  • Business Quant data shows KRSA's Receivables - Other at $400,000 (Q3 2020), $800,000 (Q2 2020) and $1.03 million (Q1 2020) in the three quarters before Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Korsana Biosciences 16.27 Mn 1.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 127,000.00
Sep 30, 2020 400,000.00
Jun 30, 2020 800,000.00
Mar 31, 2020 1.03 Mn
Dec 31, 2019 1.47 Mn
Sep 30, 2019 1.44 Mn
Jun 30, 2019 1.90 Mn
API Access

Korsana Biosciences Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=KRSA&period=max&api_key=YOUR_API_KEY